Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722263 · ClinicalTrials.gov registry record · NA
Radiotherapy for Keloids
A NA study of Keloid, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04722263: Recruiting NA study of Keloid, sponsored by Montefiore Medical Center.
NCT04722263 is a NA study of Keloid that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 15 participants, below the 2,142-participant average among 8 other Keloid trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04722263, a NA study of Keloid, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.
Primary Outcome
The number of patients with treatment related toxicities will be determined by the incidence of grade 2 or higher skin-related adverse events based on CTCAE V5.0 criteria during prescheduled study visits. The number of patients with treatment related toxicities will be reported in aggregate for all visits.
Conditions Studied
Interventions
- RADIATION Radiotherapy
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT04722263 shows while recruiting
NCT04722263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 2,142-participant average among 8 other Keloid trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 1 intervention - of which Radiotherapy is the first listed.
NCT04722263 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04722263 about?
NCT04722263 is a clinical study titled "Radiotherapy for Keloids". The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.
What is the current status of trial NCT04722263?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-12-01. Estimated completion is 2026-06.
What conditions does trial NCT04722263 study?
This clinical trial studies the following conditions: Keloid.
What interventions are being tested in trial NCT04722263?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT04722263?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722263 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keloid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04722263's enrollment target sits among peer trials
15 5th of 8 higher than 4 of 8 other Keloid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keloid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
-
"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"
COMPLETED · NA
-
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
RECRUITING · Phase 2
-
Genetic Analysis of Keloids
RECRUITING
-
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
RECRUITING
-
RAPA-Keloid Study of Keloid Regression
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI